These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 15011101)

  • 21. Topoisomerase I interactive agents.
    Kirstein MN; Turner PK; Stewart CF
    Cancer Chemother Biol Response Modif; 2002; 20():99-123. PubMed ID: 12703202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topoisomerase II inhibitors.
    Clapp JM; Hande KR
    Cancer Chemother Biol Response Modif; 2002; 20():125-49. PubMed ID: 12703203
    [No Abstract]   [Full Text] [Related]  

  • 23. CC-5013 (Celgene).
    Mitsiades CS; Mitsiades N
    Curr Opin Investig Drugs; 2004 Jun; 5(6):635-47. PubMed ID: 15242253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
    Mitra AP
    IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
    [No Abstract]   [Full Text] [Related]  

  • 25. OSI-461 (OSI).
    Galmarini CM
    Curr Opin Investig Drugs; 2004 Jun; 5(6):648-56. PubMed ID: 15242254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLK-286.
    Verschraegen CF; Smith HO; Lee FC; Cathcart C; Norenberg JP
    IDrugs; 2004 Aug; 7(8):771-81. PubMed ID: 15334311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 27th Annual JPMorgan Healthcare Conference--BioCryst and Emergent Biosolutions.
    Croasdell G; Gale S
    IDrugs; 2009 Mar; 12(3):149-51. PubMed ID: 19333891
    [No Abstract]   [Full Text] [Related]  

  • 28. [A symphony for the camptothecins].
    Lansiaux A; Bailly C
    Bull Cancer; 2003 Mar; 90(3):239-45. PubMed ID: 12801826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs.
    Chen AY; Chou R; Shih SJ; Lau D; Gandara D
    Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitors: from bench to clinic.
    Paris M; Porcelloni M; Binaschi M; Fattori D
    J Med Chem; 2008 Mar; 51(6):1505-29. PubMed ID: 18247554
    [No Abstract]   [Full Text] [Related]  

  • 31. Emerging DNA topisomerase inhibitors as anticancer drugs.
    Denny WA
    Expert Opin Emerg Drugs; 2004 May; 9(1):105-33. PubMed ID: 15155139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MS-209 Schering.
    Robert J
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1340-7. PubMed ID: 15648956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 14-azacamptothecin: a potent water-soluble topoisomerase I poison.
    Cheng K; Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    J Am Chem Soc; 2005 Jan; 127(3):838-9. PubMed ID: 15656613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epothilone D (Kosan/Roche).
    Kolman A
    Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Learning from exceptional drug responders.
    Mullard A
    Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081
    [No Abstract]   [Full Text] [Related]  

  • 36. BAY-43-9006 Bayer/Onyx.
    Lee JT; McCubrey JA
    Curr Opin Investig Drugs; 2003 Jun; 4(6):757-63. PubMed ID: 12901237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in topoisomerase I-targeting agents, camptothecin analogues.
    Kim DK; Lee N
    Mini Rev Med Chem; 2002 Dec; 2(6):611-9. PubMed ID: 12370044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.
    Manikumar G; Wadkins RM; Bearss D; Von Hoff DD; Wani MC; Wall ME
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5377-81. PubMed ID: 15454230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New anticancer agents.
    Weiss GR; Burris 3rd HA; Eckardt JR; Eckhardt SG; Fields SM; O'Rourke T; Rodriguez GI; Rothenberg ML; Valley AJ
    Cancer Chemother Biol Response Modif; 1996; 16():132-67. PubMed ID: 8639381
    [No Abstract]   [Full Text] [Related]  

  • 40. New drugs target hypoxia response in tumors.
    Garber K
    J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.